Compare RDW & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDW | LIVN |
|---|---|---|
| Founded | 2020 | 1987 |
| Country | United States | United Kingdom |
| Employees | 1410 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | N/A | 2015 |
| Metric | RDW | LIVN |
|---|---|---|
| Price | $15.19 | $79.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $13.71 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 53.8M | 634.7K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | N/A | N/A |
| Revenue This Year | $41.68 | $9.79 |
| Revenue Next Year | $20.25 | $6.63 |
| P/E Ratio | ★ N/A | $199.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.87 | $41.02 |
| 52 Week High | $26.64 | $80.74 |
| Indicator | RDW | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 67.86 |
| Support Level | $7.48 | $61.63 |
| Resistance Level | $26.64 | N/A |
| Average True Range (ATR) | 2.68 | 2.62 |
| MACD | -0.91 | 0.38 |
| Stochastic Oscillator | 4.31 | 87.44 |
Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.